Quick Facts

• Investigational Use: Management of specific cancers (e.g., Kaposi sarcoma, renal cell carcinoma)
• Common Use: Management of arthritis, joint conditions, and scaly, itchy skin (psoriasis)

---

Shark Cartilage: Main Uses and Benefits

Shark cartilage is employed as a dietary supplement for the management of several conditions, with use historically driven by non-scientific claims. Primary uses for which it has been investigated include the supportive care of certain types of cancer, such as Kaposi sarcoma and renal cell carcinoma. The purported benefit for these conditions is often associated with the presence of substances that may interfere with the growth of new blood vessels, a process known as antiangiogenesis. However, clinical trials on the use of crude shark cartilage for the treatment of various advanced cancers have yielded no significant evidence of efficacy.

Outside of oncology, shark cartilage is also frequently administered for the management of joint conditions like arthritis and psoriasis (scaly, itchy skin). Available scientific data for these applications remain limited and insufficient to definitively rate effectiveness. Shark cartilage is not approved for any therapeutic use, and some products have been found to contain environmental contaminants like neurotoxins and heavy metals.

---

Regulatory References

1. NIH National Cancer Institute PDQ cancer information summaries

Shark cartilage is regulated as a dietary supplement; therefore, official eligibility is defined by a profile of authoritative contraindications and documented restrictions rather than by an approved drug label. Only the adult population without pre-existing conditions is generally allowed to use this product.

Contraindicated Populations and Restrictions

Category	Eligibility Rule (Official Wording)
Absolute Contraindication	Individuals with Hypercalcemia (high blood calcium levels) must not use this product, as its calcium content may exacerbate the condition.
Surgical Restriction	Recent surgery or expected upcoming surgery requires that the product be avoided due to concerns that its properties could theoretically impair wound healing.
Age and Lifecycle Exclusion	Pregnancy and Lactation are status-based contraindications; use is not recommended due to insufficient reliable data on safety. Administration to children or adolescents is not established and should be avoided without medical consultation.
Conditional Caution	Caution is mandatory for patients with Renal Failure, Cardiac Arrhythmias, Autoimmune Diseases, or Liver Disease. Use is also restricted for patients with Coronary Artery Disease or Peripheral Vascular Disease.

Interactions with other medicines and products

Official regulatory information identifies specific categories of medications and products that may interact with shark cartilage, altering either its effects or the effects of the concomitant medicine.

---

Potential Interacting Categories and Implications

Interacting Category	Implication or Constraint
Immunosuppressants	Use with caution, as shark cartilage may theoretically decrease the effectiveness of the immunosuppressive agent by increasing immune activity.
Anti-hyperglycemic Agents	Blood sugar lowering effects may be enhanced, requiring close monitoring for hypoglycemia (low blood sugar).
Anti-angiogenic Agents (e.g., Thalidomide)	Caution is advised due to a theoretical risk of synergistic anti-angiogenic activity, which may impair normal wound healing.
Calcium-Containing Products	Increased risk of hypercalcemia (high blood calcium) when co-administered with calcium supplements or thiazide diuretics.

---

Administration Constraints

The oral absorption of shark cartilage may be reduced when co-ingested with acidic fruit juices (e.g., orange, apple juice). To maximize uptake, regulatory information advises separating the administration from acidic beverages by 15 to 30 minutes or consuming the mixture immediately after preparation. Use with caution is also noted for patients with diabetes or those with pre-existing conditions that affect calcium levels.

This interaction profile is primarily defined by the product's potential to affect immune function and its calcium content, which dictates the necessary precautions when used with specific therapeutic classes.

The action of shark cartilage is centered on two primary mechanisms derived from its complex structure: the anabolic and anti-catabolic regulation mediated by its glycosaminoglycans, and the anti-angiogenic activity attributed to its protein fractions. The systemic efficacy of the crude supplement is subject to mechanistic limitations, primarily digestive protease degradation.

Dual Cartilage Matrix Regulation

This domain addresses the tissue's structural integrity. Components like Glucosamine act as essential precursors, stimulating GAG biosynthesis within chondrocytes, while Chondroitin Sulfate and associated factors act as inhibitors of Matrix Metalloproteinases ( MMPs). This dual action of building and inhibiting MMP-mediated degradation of the extracellular matrix contributes to the maintenance of structural integrity and homeostasis within the tissue.

Localized Anti-Catabolic Signaling

This mechanism focuses on modulating internal processes that accelerate catabolic degradation. Active components modulate the Nuclear Factor Kappa B (NF-κB) pathway, a central transcription factor in the catabolic cascade. By downregulating NF-κB activation, the mechanism reduces the generation of pro-inflammatory mediators and tissue-degrading enzymes.

Vascular Signaling Interference

Specialized protein fractions exhibit activity as inhibitors of pro-angiogenic factors, notably Vascular Endothelial Growth Factor (VEGF). This interference suppresses endothelial cell proliferation and migration, thereby limiting neovascularization and associated tissue invasiveness—a biological process involving aberrant vascular growth. This particular mechanism, however, is significantly constrained by the poor oral bioavailability of the protein components.

Shark cartilage is primarily used via the oral route, consistent with its classification as a dietary supplement. It is available in common oral forms, including capsules, tablets, and powders, though some products may be applied topically or used as a homeopathic solution.

Dosing and Administration Status

The usage of shark cartilage is governed by its regulatory status, which impacts the level of detail provided regarding its use. There are no established standardized therapeutic dosing regimens for the product. Consequently, there is no mandated starting dose, maintenance dose, or maximum daily limit.

• Dosing and Frequency: Standardized guidelines do not specify a required daily frequency or treatment duration. Users typically follow the suggested intake provided on the manufacturer's specific product label. There is an absence of standardized usage rules when compared to prescription medications.
• Administration Conditions: General guidance for the oral form often recommends taking the supplement on an empty stomach to maximize absorption. Its use in children is generally not recommended due to theoretical concerns over interference with normal growth. Topical products are strictly intended for application to the skin and must not be taken by mouth.

Research evidence / Overview of studies for Shark cartilage

---

Research Evidence for Advanced Cancers

Research has explored the use of shark cartilage for certain advanced cancers, including advanced Non-Small Cell Lung Cancer and metastatic renal cell carcinoma. The research evaluated the product, or its purified extracts, primarily through large-scale, randomized controlled clinical trials. These studies explored outcomes related to overall patient survival, and changes in the course of illness, such as tumor size and progression.

The findings indicate that when the product was evaluated in these large randomized trials, trials reported measurements indicating no evidence regarding whether patient survival was different when added to standard therapies. Furthermore, these studies monitored tumor response and studies monitored no notable difference in progression between the treatment and placebo arms. Therefore, the evidence is limited regarding understanding the potential role for shark cartilage in these specific advanced cancers.

Research Evidence for Osteoarthritis and Joint Conditions

Shark cartilage was studied for conditions such as osteoarthritis and joint pain. The research examined outcomes related to physical discomfort, including patient-reported pain levels, as well as changes in joint function and physical stiffness. These studies explored the crude product and also its key components, chondroitin and glucosamine, often using randomized controlled trials.

Findings were mixed across the available research. Studies report how symptoms evolved in the observed populations, and high-level reviews suggest that evidence is limited for the components related to changes in pain for moderate to severe knee osteoarthritis. Due to the variability in findings, comparative evidence is lacking for the complex, crude form of shark cartilage.

Research Gaps and Inconsistent Findings

Research into shark cartilage evidence highlights what is known — and what is still uncertain. The certainty remains low across multiple key indications. Evidence quality varies across studies, often due to the sample sizes were modest and follow-up durations were limited. Furthermore, the findings were mixed between the smaller preliminary studies and the later large-scale randomized trials. Consistency and standardization between various commercially available products may impact the interpretation of research findings.

Key Studies & References

1. Cartilage (Bovine and Shark) (PDQ®) - PDQ Cancer Information Summaries
2. Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trial.
3. Osteoarthritis: In Depth | National Center for Complementary and Integrative Health (NCCIH)

Common questions about Shark cartilage (FAQ)

---

Q: Is the long-standing belief that sharks do not get cancer a scientifically verified fact?

The claim that sharks are immune to cancer is a popular belief that contributed to the product's use. However, current scientific understanding, as noted in official reviews, indicates that this claim is not a verified fact. Cases of tumors and malignancies have been documented in various shark species.

Q: Are there any known adverse effects of shark cartilage related to the immune system activity?

Studies and official information indicate that shark cartilage may increase the activity of the immune system. For individuals with existing autoimmune conditions like lupus or rheumatoid arthritis, this potential increase could theoretically lead to a worsening of symptoms. Official safety summaries indicate caution for use in individuals with these conditions.

Q: What does available information suggest about the long-term safety of shark cartilage consumption?

Chronic toxicity and the potential for long-term adverse effects have not been systematically evaluated in official safety reviews. However, regulatory summaries note that even during chronic use of large amounts, the reported side effects are generally limited to common, nonserious issues like stomach upset, nausea, and vomiting.

Q: What are the main limitations or challenges of the research studies conducted on shark cartilage?

Official reviews of the research evidence indicate several challenges that complicate the interpretation of study results. These challenges include the lack of standardized composition across different products and uncertainty about the supplement's ability to be fully absorbed by the body. Furthermore, studies have struggled to identify a single, specific active ingredient responsible for any effects.

Q: What specific conditions or ailments has shark cartilage traditionally been used for?

Historically, shark cartilage has been promoted for a range of conditions, although these uses have not been proven with research. Traditional claims included its use for the skin condition psoriasis, the vision condition macular degeneration, and as a complementary treatment for certain cancers like Kaposi's sarcoma.

Q: Is shark cartilage primarily used to help with joint stiffness or general joint pain?

Official research has examined outcomes related to both joint stiffness and the reduction of general joint pain in conditions like osteoarthritis. However, the evidence supporting the effectiveness for these specific symptoms is considered mixed. This means that consistent results across different studies have been difficult to achieve.

Q: Can taking shark cartilage affect the activity of diabetes medications?

Regulatory information notes that shark cartilage may enhance the blood sugar lowering effects of anti-hyperglycemic agents (medications for diabetes). This interaction can lead to a risk of hypoglycemia, which is abnormally low blood sugar. Official safety summaries recommend that use with these medications includes careful monitoring.

Q: Are there any specific foods or drinks known to interfere with shark cartilage absorption?

Official guidance on administration advises caution with certain beverages. Acidic fruit juices may reduce the amount of the supplement that is absorbed by the body. To support uptake, official guidance suggests separating administration from acidic beverages by 15 to 30 minutes.

Q: Does the body absorb the large protein molecules in shark cartilage capsules when swallowed?

Official reviews state that it is debated whether the body can effectively absorb the large protein molecules within the capsules. The concern is that these proteins may be broken down and rendered inactive by digestive enzymes (protease degradation) before they can be systemically absorbed.

Q: What is the difference between shark cartilage and other animal-sourced cartilage supplements like bovine cartilage?

Official regulatory and research documents often review bovine (cow) and shark cartilage together, rather than distinguishing them. Both animal sources have been the subject of research for similar purposes, including their potential use as complementary treatments for cancer and other conditions for several decades.

Q: What is the official scientific consensus on the overall efficacy of shark cartilage as a treatment?

The official scientific consensus, as stated in regulatory and government summaries, is that it is not certain whether shark cartilage is effective in treating any medical condition. Since it is sold as a dietary supplement, its medicinal use has not been approved by the FDA or other major regulatory bodies.

Q: What is the difference between a dietary supplement and a drug designation for shark cartilage?

Regulatory status is a key difference. Unlike prescription or over-the-counter drugs, dietary supplements like shark cartilage are not subject to pre-market review by the FDA for safety or effectiveness before marketing. Supplements are also not permitted to claim that they can cure, treat, or prevent specific diseases according to regulatory guidance.

Q: Why do some health experts consider shark cartilage to be a controversial supplement choice?

Official medical reviews suggest that the product is considered controversial due to several factors. These include a risk of certain side effects such as high calcium levels, official warnings regarding potential environmental contamination, and the finding that large-scale clinical studies concluded no significant benefit for serious conditions.

Q: Is the reported risk of neurotoxicity related to shark cartilage or to a specific component within it?

Regulatory safety reviews have linked the risk of neurotoxicity (harm to the nervous system) to potential contamination of the product with the neurotoxin BMAA. Furthermore, clinical trials involving the anti-angiogenic components of shark cartilage have also noted a possible association with certain adverse neurological effects.

Q: What kind of evidence is required for a shark cartilage product to make health claims?

Manufacturers of dietary supplements are required to have competent and reliable scientific evidence to support any claims they make about their product. This means the claims must be truthful and not misleading, often requiring evidence from well-designed human clinical trials that back up the stated effects.

Q: Are there any official reports of fraudulent claims or regulatory actions against shark cartilage manufacturers?

Yes, the Federal Trade Commission (FTC) has taken regulatory action against companies that sold shark cartilage products. These actions were taken due to manufacturers making unsubstantiated and fraudulent claims regarding the product's efficacy in the prevention, treatment, and cure of cancer.

Q: How is the process of harvesting shark cartilage for supplement production described?

Regulatory summaries describe the production process beginning with the cartilage being cut from the shark's skeleton, cleaned, and shredded. It is then thoroughly dried and finely ground into a powder. This final powder is often sterilized before being put into capsules or tablets for consumption.

Storage and Disposal of Shark Cartilage

Official regulatory labeling for shark cartilage products requires storage in a cool, dry place at room temperature, typically defined as below 30 C (86 F).

The product must be explicitly protected from environmental factors, including excessive heat, moisture, and direct light. For preservation, the container must be kept tightly closed and should not be used if the tamper evident seal is broken.

Mandatory Safety and Disposal

Requirement Type	Official Regulatory Statement
Child Safety	Keep out of reach of children.
Disposal	Do not flush medications down the toilet or pour into a drain; properly discard according to local waste regulations.

These storage conditions are mandatory to maintain product stability until the labeled expiration date. For powder forms, specific handling guidance may include instructions to avoid the formation of dust.